This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2024 Apr 11;390(14):1256-1258.

doi: 10.1056/NEJMp2314801. Epub 2024 Feb 28.

The End of B/Yamagata Influenza Transmission - Transitioning from Quadrivalent Vaccines

Arnold S Monto¹, Maria Zambon¹, Jerry P Weir¹

Affiliations

Affiliation

¹ From the Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor (A.S.M.); the U.K. Health Security Agency, London (M.Z.); and the Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD (J.P.W.).

PMID: 38416423
DOI: 10.1056/NEJMp2314801

The End of B/Yamagata Influenza Transmission - Transitioning from Quadrivalent Vaccines

Arnold S Monto et al. N Engl J Med. 2024.

. 2024 Apr 11;390(14):1256-1258.

doi: 10.1056/NEJMp2314801. Epub 2024 Feb 28.

Authors

Arnold S Monto¹, Maria Zambon¹, Jerry P Weir¹

Affiliation

¹ From the Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor (A.S.M.); the U.K. Health Security Agency, London (M.Z.); and the Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD (J.P.W.).

PMID: 38416423
DOI: 10.1056/NEJMp2314801

No abstract available

PubMed Disclaimer

References

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information